Showing results (1-10 of 203) with videos related to
Sort By:
Pageof 21
The Journal of Rheumatology|April 3, 2003
Hypothesis: pathogenesis of systemic sclerosisKazuhiko TakeharaSeminars in Arthritis and Rheumatism|May 1, 2012
Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokinesMinoru Hasegawa, Kazuhiko TakeharaJournal of Scleroderma and Related Disorders|April 6, 2022
Anti-nuclear autoantibodies in systemic sclerosis : News and perspectivesYasuhito Hamaguchi, Kazuhiko TakeharaExpert Review of Molecular Diagnostics|July 22, 2017
An update on biomarker discovery and use in systemic sclerosisTakashi Matsushita, Kazuhiko TakeharaJournal of Dermatological Science|April 29, 2004
Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitisYuka Shimada, Kazuhiko Takehara, Shinichi SatoThe Journal of Dermatology|August 19, 2008
Bullous pemphigoid with a prolonged prodromeTomomi Nakatani, Makoto Inaoki, Kazuhiko TakeharaInternational Journal of Rheumatic Diseases|June 28, 2019
Performance evaluation of a line blot assay system for detection of anti-PM-Scl antibody in Japanese patients with systemic sclerosisYasuhito Hamaguchi, Masataka Kuwana, Kazuhiko TakeharaClinical Rheumatology|May 10, 2020
Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodiesYasuhito Hamaguchi, Masataka Kuwana, Kazuhiko TakeharaJournal of Dermatological Science|June 15, 2004
Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgEMakoto Inaoki, Shinichi Sato, Kazuhiko TakeharaArchives of Dermatological Research|May 11, 2004
Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosisMinoru Hasegawa, Shinichi Sato, Kazuhiko TakeharaPageof 21